MeSH D006678 - hiv
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Emtricitabine, Tenofovir disoproxil, Efavirenz | Efavirenz, Emtricitabine, Tenofovir Disoproxil |  | 2018-11-09 |  |  |
| Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2017-06-08 |  |  | |
| Tenofovir disoproxil | Tenofovir Disoproxil |  | 2015-03-18 |  |  | |
| Mylan | Tenofovir disoproxil, Lamivudine | Cimduo |  | 2018-02-28 |  |  |
| Emtricitabine, Tenofovir disoproxil, Efavirenz | Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan |  | 2017-09-05 |  |  | |
| Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2018-04-09 |  |  | |
| Emtricitabine, Tenofovir disoproxil | Emtricitabine/Tenofovir disoproxil Mylan |  | 2016-12-16 |  |  | |
| Tenofovir disoproxil, Efavirenz, Lamivudine | Symfi |  | 2018-03-22 |  |  | |
| Tenofovir disoproxil, Efavirenz, Lamivudine | Symfi Lo |  | 2018-02-05 |  |  | |
| Tenofovir disoproxil | Tenofovir Disoproxil |  | 2018-11-27 |  |  | |
| Tenofovir disoproxil | Tenofovir disoproxil Mylan |  | 2016-12-08 |  |  | |
| Cipla | Emtricitabine, Tenofovir disoproxil, Efavirenz | Efavirenz, Emtricitabine, Tenofovir Disoproxil |  | 2019-06-03 |  |  |
| Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2021-04-02 |  |  | |
| Tenofovir disoproxil | Tenofovir Disoproxil |  | 2018-01-26 |  |  | |
| Chartwell Pharmaceuticals | Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2021-06-04 |  |  |
| Tenofovir disoproxil | Tenofovir Disoproxil |  | 2018-07-26 |  |  | |
| Tenofovir disoproxil, Lamivudine | Temixys |  | 2018-11-16 |  |  | |
| Merck & Co | Doravirine, Tenofovir disoproxil, Lamivudine | Delstrigo | 2031-10-07 | 2018-08-30 | $233 M | Q3/23-Q3/24 |
| Aurobindo Pharma | Emtricitabine, Tenofovir disoproxil, Efavirenz | Efavirenz, Emtricitabine, Tenofovir Disoproxil |  | 2018-09-04 |  |  |
| Tenofovir disoproxil, Efavirenz, Lamivudine | Efavirenz, Lamivudine Tenofovir Disoproxil |  | 2018-08-15 |  |  | |
| Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2018-01-26 |  |  | |
| Tenofovir disoproxil, Lamivudine | Lamivudine Tenofovir Disoproxil |  | 2018-05-15 |  |  | |
| Tenofovir disoproxil | Tenofovir Disoproxil |  | 2018-01-26 |  |  | |
| Zydus Therapeutics | Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2020-02-28 |  |  |
| Apotex | Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2021-06-16 |  |  |
| Hetero | Emtricitabine, Tenofovir disoproxil, Efavirenz | Efavirenz, Emtricitabine, Tenofovir Disoproxil |  | 2022-01-24 |  |  |
| Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2021-10-07 |  |  | |
| Tenofovir disoproxil | Tenofovir Disoproxil |  | 2018-01-26 |  |  | |
| Macleods Pharma | Emtricitabine, Tenofovir disoproxil, Efavirenz | Efavirenz, Emtricitabine, Tenofovir Disoproxil |  | 2021-09-13 |  |  |
| Tenofovir disoproxil, Efavirenz, Lamivudine | Efavirenz, Lamivudine Tenofovir Disoproxil |  | 2019-03-15 |  |  | |
| Emtricitabine, Tenofovir disoproxil | Emtricitabine Tenofovir Disoproxil |  | 2020-05-15 |  |  | |
| Tenofovir disoproxil | Tenofovir Disoproxil |  | 2018-01-26 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
72%71/99
Phase 2
46%54/117
Phase 3
47%37/78
Approved: 0Overall Success rate: 16%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use